ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.495,68
0,15%
S&P 500
5.304,72
0,70%
US Dollar vs BRL
5,1732
0,00%
Bitcoin
67.766,01
-2,34%
Brent Oil
83,105
0,31%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. TRACON Pharmaceuticals Inc (TCON)

  7. TRACON Pharmaceuticals Inc (TCON) Notícias

TCON

TRACON Pharmaceuticals (TCON)

TRACON Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TCON
DataHoraFonteTítuloCódigoCompanhia
14/05/202418:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCONTRACON Pharmaceuticals Inc
14/05/202417:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
13/05/202418:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCONTRACON Pharmaceuticals Inc
07/03/202419:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TCONTRACON Pharmaceuticals Inc
05/03/202419:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TCONTRACON Pharmaceuticals Inc
28/02/202418:02GlobeNewswire Inc.TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024NASDAQ:TCONTRACON Pharmaceuticals Inc
14/02/202418:31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCONTRACON Pharmaceuticals Inc
09/02/202418:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TCONTRACON Pharmaceuticals Inc
07/08/202318:02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TCONTRACON Pharmaceuticals Inc
25/07/202318:19Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TCONTRACON Pharmaceuticals Inc
20/06/202309:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
02/06/202317:47Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TCONTRACON Pharmaceuticals Inc
01/06/202307:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TCONTRACON Pharmaceuticals Inc
31/05/202317:22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:TCONTRACON Pharmaceuticals Inc
19/05/202318:02Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:TCONTRACON Pharmaceuticals Inc
03/05/202317:02GlobeNewswire Inc.TRACON to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 10, 2023NASDAQ:TCONTRACON Pharmaceuticals Inc
28/04/202307:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCONTRACON Pharmaceuticals Inc
06/04/202309:30GlobeNewswire Inc.Runway Growth Finance Corp. Provides First Quarter 2023 Portfolio UpdateNASDAQ:TCONTRACON Pharmaceuticals Inc
16/03/202307:02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:TCONTRACON Pharmaceuticals Inc
08/03/202319:40Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TCONTRACON Pharmaceuticals Inc
08/03/202319:19Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TCONTRACON Pharmaceuticals Inc
08/03/202319:16Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:TCONTRACON Pharmaceuticals Inc
08/03/202318:58Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
14/02/202314:58Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TCONTRACON Pharmaceuticals Inc
13/02/202319:11Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:TCONTRACON Pharmaceuticals Inc
10/01/202310:30GlobeNewswire Inc.Runway Growth Finance Corp. Provides Fourth Quarter 2022 Portfolio UpdateNASDAQ:TCONTRACON Pharmaceuticals Inc
22/11/202211:35TipRanksTRACON Pharmaceuticals (TCON) Receives a Buy from Maxim GroupNASDAQ:TCONTRACON Pharmaceuticals Inc
21/11/202212:05TipRanksH.C. Wainwright Sticks to Its Buy Rating for TRACON Pharmaceuticals (TCON)NASDAQ:TCONTRACON Pharmaceuticals Inc
16/11/202216:25TipRanksMaxim Group Remains a Buy on TRACON Pharmaceuticals (TCON)NASDAQ:TCONTRACON Pharmaceuticals Inc
15/11/202219:05TipRanksJonesTrading Sticks to Its Buy Rating for TRACON Pharmaceuticals (TCON)NASDAQ:TCONTRACON Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:TCON

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
GFSA3
GAFISA ON
BOV
AMER3
Americanas ON
BOV
AERI3
Aeris Industria E Comerc... ON
BOV
TRAD3
TC ON
BOV
COGN3
COGNA ON
BOV
TECN3
TECHNOS ON
BOV
MGLU3
MAGAZINE LUIZA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados